{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:16:03Z","timestamp":1791134163523,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is a major chronic hematologic disorder in Saudi Arabia associated with recurrent vaso-occlusive crises (VOCs), acute pain episodes, and heavy reliance on emergency department (ED) visits. Despite improvements in survival, longitudinal data on ED utilization patterns and their determinants remain limited in the region. Therefore, the aim of this study is to assess temporal trends and predictors of ED utilization among patients with SCD across multiple tertiary centers in Saudi Arabia between 2016 and 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective cohort study analyzed data from the National Guard Health Affairs (NGHA) electronic health record (EHR) system across five hospitals (Riyadh, Jeddah, Madinah, Dammam, and Al-Ahsa). The study included all patients with a confirmed SCD diagnosis (ICD-10 code D57) and at least one ED visit during the study period. After applying the eligibility criteria, 691 patients were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Demographics, comorbidities, hospital region, and prescribed ED medications, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), neuropathic agents, and benzodiazepines. The primary outcome was annual ED visits per patient. Multivariable negative binomial regression estimated incidence rate ratios (IRRs) with 95% confidence intervals (CIs), adjusted for demographics, comorbidities, and clustering by hospital site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort [mean (SD) age, 26.5 (13.6) years; 350 (50.7%) men] showed a sharp rise in ED visits from 9.2 visits in 2016 to 38.8 in 2021 (relative increase, + 76.3%;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Hospital admissions also rose from 6.3 to 13.6 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). In 2021, the mean ED visit rate [38.83 (2) \u00b1 10.59] exceeded the threshold for high ED utilization &amp;gt; 33. Male gender (IRR, 1.52; 95% CI, 1.28\u20131.81;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), older age (per 10 years: IRR, 1.27; 95% CI, 1.08\u20131.50;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006), and asthma (IRR, 1.29; 95% CI, 1.04\u20131.60;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.02) predicted higher ED utilization. Opioids were prescribed in 96.5% of visits, mostly for single-day use (93.5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ED utilization among patients with SCD from the NGHA hospitals in Saudi Arabia rose substantially between 2016 and 2021, reflecting both clinical severity and system-level care gaps. Our findings highlight the need for standardized pain protocols, comprehensive outpatient services, and Vision 2030\u2013aligned transformations to reduce preventable ED dependence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1730036","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:44:55Z","timestamp":1770273895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Temporal trends and determinants of ED visits in sickle cell disease: a multicenter EHR study from Saudi Arabia (2016\u20132021)"],"prefix":"10.3389","volume":"13","author":[{"given":"Majed","family":"Ramadan","sequence":"first","affiliation":[{"name":"Population Health Research Section, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya","family":"Bagatadah","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olwa","family":"Marwah","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Bahawi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talah","family":"Mriani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alshamrani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldanah","family":"Alzaid","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Aboulola","sequence":"additional","affiliation":[{"name":"King Abdullah Specialist Children\u2019s Hospital, Ministry of National Guard-Health Affairs","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Aboalola","sequence":"additional","affiliation":[{"name":"Department of Blood and Cancer Research, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JBM.S477507","article-title":"Newer modalities and updates in the management of sickle cell disease: a systematic review.","volume":"15","author":"Patel","year":"2024","journal-title":"J Blood Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1630994","DOI":"10.3389\/fphar.2025.1630994","article-title":"Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches.","volume":"16","author":"Taher","year":"2025","journal-title":"Front Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/JBM.S406196","article-title":"A critical review of sickle cell disease burden and challenges in Sub-Saharan Africa.","volume":"14","author":"Adigwe","year":"2023","journal-title":"J Blood Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.","volume":"10","year":"2023","journal-title":"Lancet Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e65263","DOI":"10.7759\/cureus.65263","article-title":"Prevalence, risk factors, and complications of sickle cell disease in saudi arabia: a systematic review.","volume":"16","author":"Hamed","year":"2024","journal-title":"Cureus."},{"key":"B6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s43076-021-00132","article-title":"Quality of life of sickle cell disease patients after hematopoietic stem cell transplantation: a longitudinal study.","volume":"30","author":"dos Santos Lot\u00e9rio","year":"2022","journal-title":"Trends Psychol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/IJGM.S393233","article-title":"The burden of sickle cell disease in Saudi Arabia: a single-institution large retrospective study.","volume":"16","author":"Bin Zuair","year":"2023","journal-title":"Int J Gen Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/jcm14103494","article-title":"Position paper on the management of sickle cell disease in saudi arabia: understanding disease landscape, identifying challenges, and exploring opportunities in transfusion therapies.","volume":"14","author":"AlHumaidan","year":"2025","journal-title":"J Clin Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2147\/IJGM.S461778","article-title":"Predictive factors for 30-day readmission and increased healthcare utilization in sickle cell disease patients: a single-center comparative retrospective study.","volume":"17","author":"Alshabanat","year":"2024","journal-title":"Int J Gen Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101038","DOI":"10.1016\/j.vhri.2024.101038","article-title":"Economic burden of sickle cell disease in Saudi Arabia.","volume":"45","author":"Shdaifat","year":"2025","journal-title":"Value Health Reg Issues."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102011","DOI":"10.1016\/j.cegh.2025.102011","article-title":"Saudi in vaso-occlusive crisis accessing healthcare for pain management: a qualitative study.","volume":"33","author":"Alqahtani","year":"2025","journal-title":"Clin Epidemiol Glob Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.15537\/smj.2020.12.05585","article-title":"The relation between regular outpatient follow-up and frequency of emergency department visits in sickle cell pediatric patients.","volume":"41","author":"Ismail","year":"2020","journal-title":"Saudi Med J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jamainternmed.2023.8538","article-title":"Opioid prescribing and outcomes in patients with sickle cell disease post-2016 CDC guideline.","volume":"184","author":"Kang","year":"2024","journal-title":"JAMA Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.lana.2025.101214","article-title":"Ten-year trends in opioid prescribing and vaso-occlusive crises in sickle cell disease: a population-based national cohort study (2011-2022).","volume":"50","author":"Xu","year":"2025","journal-title":"Lancet Reg Health Am."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/cells13110934","article-title":"End organ affection in sickle cell disease.","volume":"13","author":"Bathla","year":"2024","journal-title":"Cells."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0265342","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care.","volume":"17","author":"Phillips","year":"2022","journal-title":"PLoS One."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"RECORD working committee. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2513361","DOI":"10.1001\/jamanetworkopen.2025.13361","article-title":"Redefining high emergency department utilization for sickle cell disease.","volume":"8","author":"Tanabe","year":"2025","journal-title":"JAMA Netw Open."},{"key":"B20","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1038\/s41598-020-73883-7","article-title":"Negative binomial mixed models for analyzing longitudinal CD4 count data.","volume":"10","author":"Yirga","year":"2020","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70059","DOI":"10.1002\/bimj.70059","article-title":"Statistical modeling to adjust for time trends in adaptive platform trials utilizing non-concurrent controls.","volume":"67","author":"Krotka","year":"2025","journal-title":"Biom J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2513361","DOI":"10.1001\/jamanetworkopen.2025.13361","article-title":"Redefining high emergency department utilization for sickle cell disease.","volume":"8","author":"Tanabe","year":"2025","journal-title":"JAMA Netw Open."},{"key":"B24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12873-016-0096-z","article-title":"Saudi SCD patients\u2019 symptoms and quality of life relative to the number of ED visits.","volume":"16","author":"Ahmed","year":"2016","journal-title":"BMC Emerg Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15537\/smj.2023.44.1.20220636","article-title":"Early recognition of pulmonary complications of sickle cell disease.","volume":"44","author":"Almusally","year":"2023","journal-title":"Saudi Med J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/03630269.2025.2462174","article-title":"Long-term survival rates of a sickle cell disease cohort in Saudi Arabia: A 2009-2023 observational study.","volume":"49","author":"Aloofy","year":"2025","journal-title":"Hemoglobin."},{"key":"B27","unstructured":"Ministry of National Guard Health Affairs Reaches Milestones Along Digital Health Transformation. IOWA Chapter HIMSS.\n          \n          2022"},{"key":"B28","volume-title":"Partnership for Health System Sustainability and Resilience (PHSSR) Saudi Arabia Report 2025.","year":"2025"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12245-019-0232-0","article-title":"Emergency medicine in Saudi Arabia: a century of progress and a bright vision for the future.","volume":"12","author":"Khattab","year":"2019","journal-title":"Int J Emerg Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1097\/01.HS9.0000851724.42845.34","article-title":"PB2224: impact of Covid-19 pandemic on patients with sickle cell disease: results from the real world assessment survey for sickle cell disease in Saudi (ROARS).","volume":"6","author":"Ezzat","year":"2022","journal-title":"Hemasphere."},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12873-024-01043-5","article-title":"Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease.","volume":"24","author":"Attell","year":"2024","journal-title":"BMC Emerg Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings.","volume":"10","author":"Fillingim","year":"2009","journal-title":"J Pain."},{"key":"B33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4314\/pamj.v8i1.71057","article-title":"Health related quality of life among adolescents with sickle cell disease in Saudi Arabia.","volume":"8","author":"Amr","year":"2011","journal-title":"Pan Afr Med J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5144\/0256-4947.2004.179","article-title":"Differences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia.","volume":"24","author":"Udezue","year":"2004","journal-title":"Ann Saudi Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fmolb.2019.00140","article-title":"Gender-Related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study.","volume":"6","author":"Ceglie","year":"2019","journal-title":"Front Mol Biosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5603\/ARM.a2021.0011","article-title":"Pulmonary complications of sickle cell disease: a narrative clinical review.","volume":"89","author":"Pervaiz","year":"2021","journal-title":"Adv Respir Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/joah.joah_67_19","article-title":"Epidemiology and characteristics of sickle cell patients admitted to hospitals in Jazan region, Saudi Arabia.","volume":"11","author":"Hazzazi","year":"2020","journal-title":"J Appl Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia.","volume":"31","author":"Jastaniah","year":"2011","journal-title":"Ann Saudi Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1971","DOI":"10.1089\/tmj.2023.0422","article-title":"Assessing patterns of telehealth use among people with sickle cell disease enrolled in medicaid during the start of the COVID-19 pandemic.","volume":"30","author":"Reeves","year":"2024","journal-title":"Telemed J E Health."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.3390\/ijerph20043767","article-title":"Prevalence of consanguineous marriage among Saudi citizens of albaha, a cross-sectional study.","volume":"20","author":"Albanghali","year":"2023","journal-title":"Int J Environ Res Public Health."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1030-1","DOI":"10.1097\/01.HS9.0000567708.40912.cf","article-title":"Outpatient follow-up is associated with reduced emergency department visits in patients with sickle cell disease: a retrospective cohort study from Riyadh, Saudi Arabia.","volume":"3","author":"Saleh","year":"2019","journal-title":"HemaSphere."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S56-63","DOI":"10.1016\/j.annemergmed.2020.08.018","article-title":"Emergency department utilization for patients living with sickle cell disease: psychosocial predictors of health care behaviors.","volume":"76","author":"Abdallah","year":"2020","journal-title":"Ann Emerg Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/healthcare13040420","article-title":"The direct medical costs of sickle cell disease in saudi arabia: insights from a single center study.","volume":"13","author":"AlRuthia","year":"2025","journal-title":"Healthcare."},{"key":"B45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.25122\/jml-2021-0070","article-title":"Transformation of health care and the new model of care in Saudi Arabia: Kingdom\u2019s vision 2030.","volume":"14","author":"Chowdhury","year":"2021","journal-title":"J Med Life."},{"key":"B46","unstructured":"Vision 2030\n          \n          2025"},{"key":"B47","volume-title":"E-Health Initiative in Digital Transformation (Vision 2030).","year":"2024"},{"key":"B48","doi-asserted-by":"publisher","first-page":"11786329221121214","DOI":"10.1177\/11786329221121214","article-title":"Healthcare transformation in saudi arabia: an overview since the launch of vision 2030.","volume":"15","author":"Alasiri","year":"2022","journal-title":"Health Serv Insights."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3390\/su16083277","article-title":"Transforming healthcare in saudi arabia: a comprehensive evaluation of vision 2030\u2019s impact.","volume":"16","author":"Mani","year":"2024","journal-title":"Sustainability."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7326\/M20-7171","article-title":"Treatment of acute pain in adults with sickle cell disease in an infusion center versus the emergency department: a multicenter prospective cohort study.","volume":"174","author":"Lanzkron","year":"2021","journal-title":"Ann Intern Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1730036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:44:57Z","timestamp":1770273897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1730036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":50,"alternative-id":["10.3389\/fmed.2026.1730036"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1730036","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1730036"}}